FDA deadline to comment on international rescheduling of cannabis nears

The U.S. Food and Drug Administration (FDA) reopened a comment period for public input in preparation for the international discussion to reschedule marijuana  as recommended by the World Health Organization (WHO).

The deadline to submit comments is Sept. 30.

The nonbinding rescheduling recommendations made by the WHO’s Expert Committee on Drug Dependence could have a significant impact on the global medical marijuana and hemp sectors if adopted by the United Nations’ Commission on Narcotic Drugs (CND).

Cannabis would remain a tightly controlled substance – allowed only for medical and scientific use – but it would no longer be included in Schedule 4, which is the category reserved for the most dangerous substances by the WHO.

The FDA received comments on scheduling recommendations last March, though only for two weeks. That’s because there was a possibility the CND would vote on the WHO recommendations later that month in Vienna.

But the vote was postponed, so the FDA reopened the comment period.

Member states didn’t vote in March because several countries, including the United States, asked for more time to consider the recommendations.

If the new recommendations are adopted, nonmedical cannabis use would remain prohibited, according to the United Nations, but that hasn’t stopped Uruguay and Canada from moving forward with their recreational marijuana programs.

Mexico is also expected to legalize later in 2019, and New Zealand is holding a referendum in 2020.

A detailed analysis of the WHO recommendations can be found here.

“The Agency believes that an additional 30 days will allow adequate time for interested persons to submit comments,” the FDA noted in a statement.

It is expected, but not guaranteed, that member states of the CND will vote on the recommendations during the 63rd session in Vienna in March 2020.

Alfredo Pascual can be reached at [email protected]

10 comments on “FDA deadline to comment on international rescheduling of cannabis nears
  1. Tom on

    Schedule 1, dumbass. Marijuana is currently under schedule 1, which is reserved for drugs with little to no medicinal value and high potential for abuse

    Reply
    • Jason on

      In the United States, you are correct, it is listed under Schedule 1. Under the World Health Organization it is considered, on their scale, a schedule 4. Please go back and re-read the article. John Rebchook is correct about that. You are correct only about the scheduling in the United States. Contrary to popular belief, there are more countries out there than just the U.S. that have different ways of classifying “narcotics”. Again please re-read and don’t insult.

      Reply
  2. Pavel Pachta on

    Cannabis and Cannabis resin are included in Schedules I and IV of the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol. Should the WHO recommendations be endorsed by the Commission on Narcotic Drugs, Cannabis and Cannabis resin would be deleted from Schedule IV and would remain in Schedule I of that Convention.

    Reply
  3. GEORGE EADY on

    ALL THE DRUG PROBLUMS OUT THERE CAN BE TRACKED TO . POT BEING ILLEGAL . IF WE HAD LEGAL POT FOR THE LAST 60 YR . THERE WOULD NOT HAVE BEEN ANY NEED FOR THE CRACK,METH, AND MOST OF THE REST OF IT . THERE WOULD BE FEW OUT THERE . BUT WHAT MANY AMERICANS HAS WONTED FOR THEM YEARS IS A NOTHER CHOICE OTHER THAN DRINKING . POT WAS PERFECT FOR THAT . POT DONT KILL. POT SMOKERS DONT KILL, AND AS WE HAVE SEEN THE LAST FEW YR . JEST HOW MUCH POT CAN HELP IN THE MEDICAL FILLED . WE WOULD HAVE KNOWN ALL OF THIS AND MORE IF NOT FOR THE U.S. GOV STOPING THE HELP IT GIVES . MAYBE THAT IS WHO SHOULD BE SUED. THERE ACTIONS CAUSES SUFFERING . IS THAT NOT THE BASE FOR A LAW SUIT

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *